Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,901 | 28,038 | 43,069 | 59,714 | 54,951 |
| Marketable Securities | 337,183 | 454,881 | 394,302 | 280,173 | 283,554 |
| Receivables | 5,000 | N/A | N/A | N/A | 417 |
| Other current assets | 0 | 0 | 0 | 243 | 0 |
| TOTAL | $386,066 | $496,718 | $451,933 | $350,770 | $345,104 |
| Non-Current Assets | |||||
| PPE Net | 4,699 | 5,819 | 7,705 | 8,148 | 1,099 |
| Investments And Advances | 0 | 0 | 21,213 | 37,495 | 0 |
| Intangibles | 0 | 3,736 | 3,736 | 3,736 | 12,536 |
| Other Non-Current Assets | 39,572 | 45,415 | 54,723 | 54,358 | 6,816 |
| TOTAL | $44,271 | $54,970 | $87,377 | $103,737 | $20,451 |
| Total Assets | $430,337 | $551,688 | $539,310 | $454,507 | $365,555 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,438 | 14,926 | 11,247 | 11,590 | 8,661 |
| Accrued Expenses | 45,287 | 54,441 | 45,400 | 32,354 | 19,940 |
| TOTAL | $52,725 | $69,367 | $56,647 | $43,944 | $28,601 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 40,454 | 45,044 | 48,093 | 51,827 | 1,804 |
| TOTAL | $40,426 | $44,930 | $48,639 | $46,081 | $3,577 |
| Total Liabilities | $93,151 | $114,297 | $105,286 | $90,025 | $32,178 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,812 | 70,960 | 59,418 | 45,563 | 41,040 |
| Common Shares | 71 | 70 | 59 | 45 | 41 |
| Retained earnings | -1,054,395 | -888,556 | -596,365 | -359,559 | -200,834 |
| Other shareholders' equity | 558 | 2,301 | -1,132 | 403 | 24,831 |
| TOTAL | $337,186 | $437,391 | $434,024 | $364,482 | $333,377 |
| Total Liabilities And Equity | $430,337 | $551,688 | $539,310 | $454,507 | $365,555 |